ABIOMED, Inc. (ABMD) Financial Statements (2025 and earlier)

Company Profile

Business Address 22 CHERRY HILL DR
DANVERS, MA 01923
State of Incorp. DE
Fiscal Year End March 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2022
MRQ
3/31/2022
3/31/2021
3/31/2020
3/31/2019
3/31/2018
3/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 132,818232,710192,341121,021362,249229,948
Cash and cash equivalent 132,818232,710192,341121,02142,97539,040
Short-term investments     319,274190,908
Receivables 90,60897,17984,65090,80970,01054,055
Inventory, net of allowances, customer advances and progress billings  81,05990,08880,94250,20434,931
Inventory  81,05990,08880,94250,20434,931
Other undisclosed current assets 753,047377,017268,784384,42511,8088,024
Total current assets: 976,473787,965635,863677,197494,271326,958
Noncurrent Assets
Operating lease, right-of-use asset  6,109 
Property, plant and equipment 202,490197,129164,931145,005117,16787,777
Long-term investments and receivables     37,50247,143
Long-term investments     37,50247,143
Intangible assets, net (including goodwill) 158,372190,61846,88247,80952,51345,527
Goodwill 76,78678,56831,96932,60135,80831,045
Intangible assets, net (excluding goodwill) 81,586112,05014,91315,20816,70514,482
Deferred income tax assets 10,55211,380 
Other noncurrent assets 147,485113,082117,65585,11514,1768,286
Deferred tax assets, net77,50270,74634,723
Other undisclosed noncurrent assets 178,021188,076251,13121,718  
Total noncurrent assets: 696,920706,394580,599377,149292,104223,456
TOTAL ASSETS: 1,673,3931,494,3591,216,4621,054,346786,375550,414
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 107,975100,888107,88189,60569,71258,323
Accounts payable 35,34634,84232,77432,18523,56520,620
Accrued liabilities 72,62966,04675,10757,42046,14737,703
Deferred revenue 26,36224,32219,147
Debt      799
Other liabilities 4,1203,7594,857   
Deferred revenue and credits14,97010,495
Contract with customer, liability16,393
Total current liabilities: 138,457128,969131,885105,99884,68269,617
Noncurrent Liabilities
Long-term debt and lease obligation      15,539
Capital lease obligations  15,539
Liabilities, other than long-term debt 31,61035,71518,30511,45812,16913,187
Deferred tax liabilities, net822903783
Deferred income tax liabilities 781847 
Other liabilities 9,31910,1629,3051,0617763,251
Business combination, contingent consideration, liability 21,51024,7069,0009,57510,4909,153
Other undisclosed noncurrent liabilities   806   
Total noncurrent liabilities: 31,61035,71519,11111,45812,16928,726
Total liabilities: 170,067164,684150,996117,45696,85198,343
Equity
Equity, attributable to parent 1,503,3261,329,6751,065,466936,890689,524452,071
Common stock 455453451451444437
Treasury stock, value (304,555)(288,030)(265,411)(138,852)(67,078)(46,763)
Additional paid in capital 870,074800,690739,133690,507619,905565,962
Accumulated other comprehensive loss (27,160)(11,445)(11,189)(14,689)(4,204)(20,606)
Retained earnings (accumulated deficit) 964,512828,007602,482399,473140,457(46,959)
Total equity: 1,503,3261,329,6751,065,466936,890689,524452,071
TOTAL LIABILITIES AND EQUITY: 1,673,3931,494,3591,216,4621,054,346786,375550,414

Income Statement (P&L) ($ in thousands)

9/30/2022
TTM
3/31/2022
3/31/2021
3/31/2020
3/31/2019
3/31/2018
3/31/2017
Revenues 1,031,753847,522840,883769,432593,749445,304
Revenue, net 445,304
Cost of revenue (276,009)(161,907)(151,305)(129,567)(98,581)(70,627)
Cost of product and service sold (188,158)(161,907)(151,305)(129,567)(3,946)(70,627)
Gross profit: 755,744685,615689,578639,865495,168374,677
Operating expenses (615,024)(456,058)(440,359)(415,053)(338,031) 
Other undisclosed operating loss      (284,539)
Operating income: 140,720229,557249,219224,812157,13790,138
Nonoperating income 49,84058,6637,60638,5483,3001,205
Investment income, nonoperating  6,71712,1678,1663,6881,554
Other nonoperating income (expense) 49,84051,946(4,561)30,382(388)(349)
Other undisclosed loss from continuing operations before equity method investments, income taxes      (1)
Income from continuing operations before equity method investments, income taxes: 190,560288,220256,825263,360160,43791,342
Other undisclosed income from continuing operations before income taxes      1
Income from continuing operations before income taxes: 190,560288,220256,825263,360160,43791,343
Income tax expense (54,055)(62,695)(53,816)(4,344)(48,267)(39,227)
Income from continuing operations: 136,505225,525203,009259,016112,17052,116
Income before gain (loss) on sale of properties:136,505225,525203,009259,016112,17052,116
Net income available to common stockholders, diluted: 136,505225,525203,009259,016112,17052,116

Comprehensive Income ($ in thousands)

9/30/2022
TTM
3/31/2022
3/31/2021
3/31/2020
3/31/2019
3/31/2018
3/31/2017
Net income: 136,505225,525203,009259,016112,17052,116
Other comprehensive income (loss) (15,715)(256)3,500(10,485)16,402(6,066)
Comprehensive income, net of tax, attributable to parent: 120,790225,269206,509248,531128,57246,050

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: